Re: I thought we'd have some news on the loan today....
|
6
|
Resverlogix Corp.
|
Sep 13, 2019 01:58PM
|
Re: 2019 Potential Events
|
6
|
Resverlogix Corp.
|
Apr 18, 2019 11:39AM
|
Norman Wong presenting at Alberta Epigenetics Network Summit 3/22
|
6
|
Resverlogix Corp.
|
Mar 21, 2016 11:25AM
|
Re: I would like to see in the next week or so,...
|
6
|
Resverlogix Corp.
|
Aug 31, 2019 08:01PM
|
Re: New publication
|
6
|
Resverlogix Corp.
|
Sep 23, 2019 12:59PM
|
Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
6
|
Resverlogix Corp.
|
Nov 02, 2020 07:46AM
|
FSHD and apabetalone topical formulation
|
6
|
Resverlogix Corp.
|
Feb 27, 2019 01:36PM
|
Re: CANTOS and CIRT
|
6
|
Resverlogix Corp.
|
Jan 15, 2018 12:27PM
|
Re: Happy Anniversary
|
6
|
Resverlogix Corp.
|
Mar 20, 2019 09:50AM
|
Re: anyone thinking halt for NR before presentation tomorrow?
|
6
|
Resverlogix Corp.
|
Oct 12, 2016 09:09PM
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
6
|
Zenith Epigenetics
|
Jul 22, 2019 10:17AM
|
Vorapaxar and anti-platelet therapy
|
6
|
Resverlogix Corp.
|
Aug 10, 2018 12:44PM
|
Re: NIH Halts Large Cardiovascular Inflammation Reduction Trial (CIRT)
|
6
|
Resverlogix Corp.
|
Sep 25, 2018 12:48PM
|
Zacks SCR 11/4/2019: RVX.TO: SOME CLARITY ON THE PATH FORWARD
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 02:35PM
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
6
|
Resverlogix Corp.
|
Jul 09, 2020 11:57AM
|
Re: 50% Discount to China deal ...
|
6
|
Resverlogix Corp.
|
Mar 22, 2016 01:18PM
|
Re: German drug maker Morphosys to buy Constellation Pharma in $1.7 billion deal
|
6
|
Zenith Epigenetics
|
Jun 03, 2021 12:33PM
|
Re: Pointing in the right direction & bogus Lilly
|
6
|
Resverlogix Corp.
|
Jun 21, 2018 03:23PM
|
Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
6
|
Resverlogix Corp.
|
Aug 29, 2019 06:30AM
|
Re: What would an update really tell us?
|
6
|
Resverlogix Corp.
|
Jul 18, 2015 10:31PM
|